Clinical trial
Glycocalyx Damage During Normothermic Graft Perfusion in Orthotopic Liver Transplantation - A Pilot Study
NCT04764266 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glycocalyx Damage During Normothermic Graft Perfusion in Orthotopic Liver Transplantation - A Pilot Study
- Lead sponsor
- Medical University Innsbruck
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 10, 2021
- Completion date
- February 1, 2024
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glycocalyx, liver transplantation